---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-060556"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-05-22T20:05:31+00:00"
generated_at: "2026-05-22T20:08:01.459469+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical receives Nasdaq extension to November 16, 2026 to cure bid price deficiency

## Summary
- Company received Nasdaq notice granting additional 180-day period until November 16, 2026 to meet $1.00 minimum bid price.
- Initial compliance period ended May 18, 2026; company had not yet satisfied the bid price requirement.
- Extension based on meeting other listing requirements and written intent to cure via reverse stock split if needed.
- If not cured by new deadline, common stock may be delisted from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-26-060556
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-05-22T20:05:31+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/ea0292043-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-060556
- JSON: https://secwatch.observer/filing/0001213900-26-060556.json
- Plain text: https://secwatch.observer/filing/0001213900-26-060556.txt

## Source-grounded claims
- claim_id: b6bfe89869c8cd123c9ece33912fd4738be76fa9
  claim: Envoy Medical, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: On May 19, 2026, the Company received a second staff notification from Nasdaq informing the Company that, although the Company had not met the Bid Price Requirement by the Compliance Date, the Company is eligible for an additional 180 day period, until November 16, 2026, to meet the Bid Price Requirement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.